A novel one-pot tandem biohydrogen transfer process to concurrently obtain two enantiopure sec-alcohols is presented; thus, using a suitable single enzyme and a catalytic amount of cofactor several interesting building blocks could be easily achieved in an enantiocomplementary fashion minimizing dramatically the quantity of reagents usually employed in the 'coupledsubstrate' approach.
Several (bio)catalytic methods to synthesize enantiopure secondary alcohols have been developed in the last few years to fulfill the increasing demand of this type of highly valuable compounds. 1 Among all methodologies described, stereoselective reduction of ketones 2 and enantioselective oxidation of racemic sec-alcohols 3 using hydrogen transfer (HT) protocols have extensively been studied due to the mild and simple conditions employed in these transformations. In this context, biocatalyzed HT (also called 'coupled-substrate' approach) employing alcohol dehydrogenases (ADHs) has recently gained increasing relevance. 4 In these processes, a single enzyme reduces/oxidizes the target substrate sacrificing a small molecule (cosubstrate) like 2-propanol/acetone as hydride donor/acceptor, used in a huge molar excess (at least 10 equiv. compared to 1 equiv. substrate to afford conversions higher than 90%) due to the reversible character of the reaction. Very recently, it has been described that small activated ketones such as methyl acetoacetate 5 or chloroacetone 6 can be employed as cosubstrates in ADH-catalyzed oxidation of alcohols in near stoichiometric amount to achieve complete conversion. Herein, we present a system in which the sacrificial reaction has been turned into a highly valuable transformation, resulting in a one-pot process combining activated ketones with racemic sec-alcohols in order to concurrently obtain two different optically enriched alcohols catalyzed by a single enzyme maximizing thus the atom efficiency environmental factor E 7 of the process, since no additional reagent is discarded. Therefore, starting from a prochiral ketone and a racemic alcohol, we can obtain two optically pure alcohols (Scheme 1). Another advantage of this system is that the stereoselectivity can be tuned by simply changing the biocatalyst employed.
In a first set of experiments, we studied the influence of the ketone structure on some selected ADH-catalyzed reductions using a low excess of the cosubstrate (2 equiv. of 2-propanol, see Supporting Information). Thus, several ketones were reduced using a Prelog (ADH-A from Rhodococcus ruber), 8 or an anti-Prelog [ADH from Lactobacillus brevis (LB-ADH)] 9 enzyme. It could be observed that non-activated ketones like acetophenone afforded 50% conversion. When p-substituted acetophenones were reduced, electron donating groups provided low conversions (<30%), while electron withdrawing substituents afforded conversions about 80%. Moreover, ketones with an electron withdrawing group at α-position such as α-chloroacetophenone furnished quantitative conversions. These results can be explained due to the different oxidationreduction potentials (ΔE O ) between the ketone/alcohol pair with regards to the 2-propanol/acetone counterpart. 10 It has been shown that α-halohydrins are stabilized via intramolecular H-bond between the alcohol moiety and the halogen atom, 11 therefore preventing the ADH-catalyzed oxidation. Taking as an advantage the irreversibility of this HT, we tested the concept in a one-pot tandem protocol to simultaneously obtain two enantiopure sec-alcohols (see Scheme of Table 1 ). In theory, an irreversible asymmetric reduction is required to achieve a complete kinetic oxidative resolution, thus a molar amount of ketone to be reduced can be equal or slightly higher than the molar amount of alcohol to be oxidized. Thus, mixing an activated ketone (1 equiv.) with a racemic alcohol (1.8-2 equiv.), the selective reduction of the prochiral compound plus the kinetic resolution of the racemate could be achieved via HT by a single enzyme and a catalytic amount of the pyrimidinic cofactor which is internally recycled. Due to the perfect selectivity shown by the biocatalysts utilized, the hydride is abstracted from a single enantiomer of the racemic alcohol, and then exclusively transferred to one stereo-face of the prochiral ketone.
Therefore, several α-chloro-, α-azido-, and α-cyano ketones (1a-k, Table 1 ) were purchased or synthesized and then combined with racemic 2-octanol (3a). Except for the cyano derivative 1i (entry 9), we were able to find a suitable Prelog and anti-Prelog ADH to obtain enantioenriched or enantiopure (R)-or (S)-3a using activated aliphatic and (hetero)aryl ketones, which were reduced to the corresponding enantiopure alcohols with very high yields. Compounds with electron donating groups in the phenyl ring (1b, entry 2), afforded lower conversions. By simply changing the enzyme, enantiocomplementary products could be achieved. Thus, ADH-A or LB-ADH were usually employed, but in some cases Thermoanaerobacter sp. ADH (ADH-T) 12 or PR2 provided better results. As an example, we scaled-up the reaction of 2k with LB-ADH up to a substrate concentration of 400 mM, showing the great robustness of the system. The obtained α-activated alcohols are important precursors of pharmaceutical compounds. For instance, (S)-2a is an intermediate for the synthesis of fluoxetine, tomoxetine, and nisoxetine, 13 (R)-2b can be used as precursor of β-agonists like octopamine or denopamine, 14 and optically active 2k is a useful chiral building block for the synthesis of different pharmaceuticals. 15 On the other hand, several sec-alcohols were resolved using chloro ketone 1e with ADH-A, and 1k with LB-ADH (Table  2) . Thus, aromatic (3b-d), aliphatic (3e-f) such as sulcatol, or cycloalkyl (3g) derivatives could be successfully obtained in enantioenriched form via tandem concurrent HT. In summary, we have demonstrated a novel one-pot tandem system to simultaneously obtain two enantiopure sec-alcohols that possesses several advantages: conversion can be easily controlled by the amount of racemic alcohol added, a single biocatalyst and catalytic amount of cofactor are used, the selectivity can be tuned by choosing the appropriate enzyme, and the process can be scaled-up. 16 This is an elegant example that shows how biocatalysis can be applied for the "clean" synthesis of valuable enantiopure compounds maximizing the atom efficiency. 7
Experimental Section
General. Alcohol dehydrogenases, ketones 1a, 1d, 1e, 1i,  1k, racemic alcohols 3a, 3b, 3c, 3d, 3e, 3f and 3g, and their corresponding ketones were purchased from commercial sources. α -Chloro ketones 1b, 1c, 1f, 1g , and 1j were synthesized following modified protocols described in the literature.
17 α-Azido ketone 1h was obtained as published before.
8a Racemic alcohols 2a-k were synthesised by conventional reduction from the corresponding ketones (NaBH 4 , MeOH, room temperature). All other reagents and solvents were of the highest quality available. 1 unit (U) of ADH reduces 1.0 μM of acetophenone to 1-phenylethanol per minute at pH 7.5 and 30ºC in the presence of NAD(P)H. Flash chromatography was performed using silica gel 60 (230-400 mesh).
General procedure for the tandem concurrent biohydrogen transfer using activated ketones and 2-octanol. In a 1.5 mL Eppendorf vial, 3-5 U of commercially available ADH (Lactobacillus brevis ADH, Rhodococcus ruber ADH-A, Thermoanaerobacter sp. ADH or PR2 ADH) in Tris-HCl buffer [50 mM, pH 7.5, 1 mM NAD(P)H, 1 mM MgCl 2 for LB-ADH] were mixed with both the racemic 2-octanol and the prochiral ketone (1a-k) in a 1.8-2:1 molar ratio respectively (e.g., 90-100 mM racemic 3a and 50 mM ketone) in a final volume of 0.6 mL. The reaction was incubated at 30 ºC and orbital rotation (150 rpm) for 24h. Then, the reaction was stopped by extraction with ethyl acetate (2 x 0.6 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried (Na 2 SO 4 ). Conversions and enantiomeric excesses of the corresponding alcohols were determined by GC or HPLC analysis using an achiral or chiral stationary phase, respectively.
General procedure for the resolution of sec-alcohols via ADH-catalyzed tandem HT mediated by α-chloro ketones. In a 1.5 mL Eppendorf vial, 3-5 U of commercially available ADH (LB-ADH or ADH-A) in Tris-HCl buffer [50 mM, pH 7.5, 1 mM NAD(P)H, 1 mM MgCl 2 for LB-ADH] were mixed with both the racemic alcohol (3b-g, 90-100 mM) and the prochiral ketone (1e for ADH-A or 1k for LB-ADH, 50 mM) in a final volume of 0.6 mL. The reaction was incubated at 30 ºC and orbital rotation (150 rpm) for 24h. Then, the reaction was stopped by extraction with ethyl acetate (2 x 0.6 mL). The organic layer was separated by centrifugation (2 min, 13000 rpm) and dried (Na 2 SO 4 ). Conversions and enantiomeric excesses of the corresponding alcohols were determined by GC or HPLC analysis using an achiral or chiral stationary phase, respectively.
